Wes Streeting, Governance-ESGUK Approves Lecanemab for Alzheimer's Treatment67% right coverage3 sources
Wes Streeting, Governance-ESGUK Approves Lecanemab for Alzheimer's Treatment67% right coverage3 sources
Wes Streeting, Governance-ESGUK Approves Alzheimer's Drug Leqembi Amid Cost Concerns40% left coverage11 sources
Wes Streeting, Governance-ESGUK Approves Alzheimer's Drug Leqembi Amid Cost Concerns40% left coverage11 sources